Indications & Dose:

Psoriatic arthritis | Ankylosing spondylitis 

• BY SUBCUTANEOUS INJECTION

Adult: 150 mg every week for 5 doses, then maintenance 150 mg every month, review treatment if no response within 16 weeks of initial dose

Psoriatic arthritis with concomitant moderate to severe plaque psoriasis or if inadequate response to anti-TNFa treatment | Plaque psoriasis 

• BY SUBCUTANEOUS INJECTION

Adult: 300 mg every week for 5 doses, then maintenance 300 mg every month, review treatment if no response within 16 weeks of initial dose

Contraindications:

Severe active infection

Cautions:

Chronic infection . Crohn’s disease (monitor for exacerbations) . history of recurrent infection . predisposition to infection (discontinue if new serious infection develops)

Precautions:

Interaction:

Warnings:

Adverse Effects:

Lactations:

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

Patient And Carer Advice: